Target
Retinol-binding protein 4
Ligand
BDBM135828
Substrate
n/a
Meas. Tech.
Binding Assay
pH
7.5±n/a
Temperature
277.15±n/a K
IC50
49±n/a nM
Comments
extracted
Citation
 Kasai, SMcGee, Jr., KF Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes US Patent  US8853215 Publication Date 10/7/2014 
Target
Name:
Retinol-binding protein 4
Synonyms:
PRBP | Plasma retinol-binding protein | RBP | RBP4 | RET4_HUMAN | Retinol-binding protein 4 | Retinol-binding protein 4 (RBP4) | spa binding assay for rbp4
Type:
Protein
Mol. Mass.:
23008.75
Organism:
Homo sapiens (Human)
Description:
P02753
Residue:
201
Sequence:
MKWVWALLLLAALGSGRAERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYCDGRSERNLL
  
Inhibitor
Name:
BDBM135828
Synonyms:
US8853215, 19
Type:
Small organic molecule
Emp. Form.:
C23H26N4O3
Mol. Mass.:
406.4775
SMILES:
CC(C)(C)c1ccccc1N1CCN(CC1)C(=O)c1ccc(cc1)-c1noc(=O)[nH]1
Structure:
Search PDB for entries with ligand similarity: